alantolactone has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, Y; Fu, C; Li, Z; Niu, M; Pan, B; Qiao, J; Sun, Y; Wu, Q; Xia, D; Xu, K; Yao, Y; Zhao, K; Zhu, F | 1 |
| Li, ZY; Niu, MS; Sun, YY; Xia, DD; Xu, KL; Yao, Y; Zeng, LY; Zhao, K | 1 |
2 other study(ies) available for alantolactone and Multiple Myeloma
| Article | Year |
|---|---|
Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance.
Topics: Antineoplastic Agents; Apoptosis; Bortezomib; Caspases; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; G1 Phase Cell Cycle Checkpoints; Humans; Lactones; MAP Kinase Signaling System; Multiple Myeloma; Phosphorylation; Sesquiterpenes, Eudesmane; Tumor Microenvironment | 2015 |
[Effect of Alantolactone on Proliferation of RPMI-8226 Cells and Its Possible Mechnism].
Topics: Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Humans; Lactones; Mice; Mice, Nude; Multiple Myeloma; Sesquiterpenes, Eudesmane; Signal Transduction | 2015 |